Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+ gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03

Yelena Y. Janjigian; Do-Youn Oh; Sun Young Rha; Keun Wook Lee; Neeltje Steeghs; Yee Chao; Maria Di Bartolomeo; Marc Díez Garcia; Nadia Haj Mohammad; Alexander Stein; William McAdoo; Megan Winter; Liz Croydon; Jeeyun Lee

doi:10.1200/JCO.2022.40.4_suppl.295

YUHSpace

BROWSE

0 365

Cited 0 times in

Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+ gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03

Authors: Yelena Y. Janjigian ; Do-Youn Oh ; Sun Young Rha ; Keun Wook Lee ; Neeltje Steeghs ; Yee Chao ; Maria Di Bartolomeo ; Marc Díez Garcia ; Nadia Haj Mohammad ; Alexander Stein ; William McAdoo ; Megan Winter ; Liz Croydon ; Jeeyun Lee